The global amniotic membrane market was valued at $1,102.45 million in 2020 and is projected to reach $1,728.05 million by 2030, registering a CAGR of 4.6% from 2021 to 2030.
Amniotic membrane is the inmost layer of the placenta, which includes a thick basement membrane or a tissue and an avascular stromal matrix. This membrane has the ability to promote healing; thus, it is utilized in surgical procedures related to Genito-urinary tract, skin, brain, and head and neck. In addition, amniotic membrane is increasingly used for ocular surface reconstruction, including the treatment of persistent epithelial defects and non-healing corneal ulcers, corneal perforations and descemetoceles, bullous keratopathy, as well as corneal disorders with associated limbal stem cell deficiency.
The major factors that drive the growth of the global amniotic membrane market include rise in amniotic membrane transplantation and rise in awareness and education about the benefits of amniotic membrane transplantation. In addition, technological innovations to develop cost-effective therapies are expected to lead to a paradigm shift in the amniotic membrane market globally. However, lack of healthcare professionals restricts the market growth.
The global amniotic membrane market is segmented on the basis of type of product, application, end user and region. According to product type, the market is divided into cryopreserved amniotic membrane and lyophilization amniotic membrane. On the basis of applications, the market is divided into surgical wounds, ophthalmology, and others. On the basis of end user, the market is divided into hospitals, ambulatory surgical centers, specialized clinics, and research center & laboratories. Regionally, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA).
The major companies profiled in the report include AlloSure, Inc., Amnio Technology, LLC, Applied Biologics LLC, FzioMed, Inc., Human Regenerative Technologies, LLC, Integra Lifesciences Holdings Corporation, Corza Ophthalmology, MiMedx Group, Inc, Skye Biologics Inc., and TissueTech, Inc.
Amniotic membrane is the inmost layer of the placenta, which includes a thick basement membrane or a tissue and an avascular stromal matrix. This membrane has the ability to promote healing; thus, it is utilized in surgical procedures related to Genito-urinary tract, skin, brain, and head and neck. In addition, amniotic membrane is increasingly used for ocular surface reconstruction, including the treatment of persistent epithelial defects and non-healing corneal ulcers, corneal perforations and descemetoceles, bullous keratopathy, as well as corneal disorders with associated limbal stem cell deficiency.
The major factors that drive the growth of the global amniotic membrane market include rise in amniotic membrane transplantation and rise in awareness and education about the benefits of amniotic membrane transplantation. In addition, technological innovations to develop cost-effective therapies are expected to lead to a paradigm shift in the amniotic membrane market globally. However, lack of healthcare professionals restricts the market growth.
The global amniotic membrane market is segmented on the basis of type of product, application, end user and region. According to product type, the market is divided into cryopreserved amniotic membrane and lyophilization amniotic membrane. On the basis of applications, the market is divided into surgical wounds, ophthalmology, and others. On the basis of end user, the market is divided into hospitals, ambulatory surgical centers, specialized clinics, and research center & laboratories. Regionally, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA).
The major companies profiled in the report include AlloSure, Inc., Amnio Technology, LLC, Applied Biologics LLC, FzioMed, Inc., Human Regenerative Technologies, LLC, Integra Lifesciences Holdings Corporation, Corza Ophthalmology, MiMedx Group, Inc, Skye Biologics Inc., and TissueTech, Inc.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the global amniotic membrane market, with current trends and future estimations to elucidate the imminent investment pockets
- Comprehensive analysis of factors that drive and restrict the market growth is provided detailed quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities
- Extensive analysis of the key segments of the industry helps understand the type of products and applications used globally
- Key market players and their strategies are provided to understand the competitive outlook of the market
By Product
- Cryopreserved Amniotic Membrane
- Lyophilization Amniotic Membrane
By Application
- Surgical Wounds
- Ophthalmology
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Specialized Clinics
- Research Centers & laboratories
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY PLAYERS
- Allosure, Inc
- Amnio Technology, LLC
- Applied Biologics LLC
- FzioMed, Inc
- Human Regenerative Technologies, LLC
- Integra Lifesciences Holdings Corporation
- Corza Ophthalmology
- MiMedx Group, Inc
- Skye Biologics Inc
- TissueTech, Inc
Table of Contents
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Landscape
Chapter 4: Amniotic Membrane Market, by Product Type
Chapter 5: Amniotic Membrane Market, by Application
Chapter 6: Amniotic Membrane Market, by End-user
Chapter 7: Amniotic Membrane Market, by Region
Chapter 8: Company Profiles
List of Tables
List of Figures
Executive Summary
According to a new report titled, “Amniotic Membrane Market by Product Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030,” The global amniotic membrane market size was valued at $1,102.45 million in 2020 and is projected to reach $1,728.05 million by 2030, registering a CAGR of 4.6% from 2021 to 2030.Amniotic membrane is the innermost layer forming the fetal membranes. It is used as a graft or as a dressing in different surgical subspecialties. In the field of ophthalmology, this tissue is used as a tissue bandage for cornea infections and sterile melts, and to reconstruct the ocular surface for various procedures. In addition, this membrane protects and stimulates the repair of injured tissues via paracrine actions and also acts as a vector for bio-delivery of exogenous factors to treat injury and ailments. Also, the anti-inflammatory property of transplanted amniotic membrane is used as therapy against chronic inflammation in geriatric population. In addition, amniotic membrane is increasingly used for ocular surface reconstruction, including the treatment of persistent epithelial defects and non-healing corneal ulcers, corneal perforations and descemetoceles, bullous keratopathy, a corneal disorders with associated limbal stem cell deficiency.
Increase in the rapid expansion of the geriatric population and increase in adoption of amniotic membrane for varied applications are expected to drive the market growth. In addition, technological innovations to develop cost-effective therapies are expected to lead to a paradigm shift in the amniotic membrane market, globally. However, lack of healthcare professionals is expected to impede the market growth.
On the basis of product type, the global amniotic membrane market is categorized as cryopreserved amniotic membrane and lyophilization amniotic membrane. Lcryopreserved amniotic membrane is expected to dominate the market during the forecast period as this membrane can be stored at ambient temperatures for prolonged periods. Lyophilization amniotic membrane is expected to register a CAGR of 5.2% during the forecast period. Increase in awareness among patients towards the diagnosis and treatment options for amniotic membrane transplantation is expected to increase the growth of the market. Moreover, several pharmaceutical companies focus on developing products for the amniotic membrane transplantation, which is expected to drive the growth of the market during the forecast period.
On the basis of application, the surgical wound segment accounted for a major share of the market in the global amniotic membrane market in 2020. Owing to the rise in number of chronic and infectious diseases, a global rise in the number of surgeries has been witnessed that boosts the market potential. In addition, the ophthalmology segment is expected to register a CAGR of 4.9% during the forecast period. This segment is expected to exhibit a prominent growth rate, owing to the utilization of amniotic membrane, which leads to faster recovery of various eye-associated ailments.
On the basis of end user, the hospitals segment presently dominates the market, and is expected to remain dominant during the forecast period, due to frequent visits by patients, as hospitals are the primary care settings facilitating easy treatment for a wide range of diseases. The rise in usage of amniotic membranes in ASCs is another factor that is expected to enhance the market growth. The use of these products is easy and effective and also facilitates recovery of the wound without frequent visits to hospitals or clinics, which further drives the growth of market.
North America accounted for more than 40% of the global market share in 2020, and is expected to remain dominant during the forecast period. This was attributed to the well-established healthcare system and increase in adoption of amniotic membrane transplantation for varied applications, increase in number of geriatric patients, and supportive reimbursement policies in the healthcare system. Asia-Pacific is projected to register the highest CAGR of 5.9% during the forecast period. Rise in disposable income and presence of large geriatric population in developing countries are expected to drive the growth of amniotic membrane market in the region. In addition, increase in healthcare expenditure offers a lucrative opportunity for the market growth.
The major companies profiled in the report include AlloSource, Inc, Amnio Technology, LLC, Applied Biologics LLC, FzioMed, Inc., Human Regenerative Technologies, LLC, Integra Lifesciences Holdings Corporation, Corza Ophthalmology, MiMedx Group, Inc, Skye Biologics Inc., and TissueTech, Inc.
Key Findings Of Study
- The study provides an in-depth analysis of the global amniotic membrane market, with current trends and future estimations to elucidate the imminent investment pockets
- Comprehensive analysis of factors that drive and restrict the amniotic membrane market growth is provided
- A detailed quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing amniotic membrane market opportunities
- Extensive analysis of the key segments of the industry helps understand the type of products and applications used globally
- Key players and their strategies are provided to understand the competitive outlook of the amniotic membrane market
Companies Mentioned
- Allosure, Inc
- Amnio Technology, LLC
- Applied Biologics LLC
- FzioMed, Inc
- Human Regenerative Technologies, LLC
- Integra Lifesciences Holdings Corporation
- Corza Ophthalmology
- MiMedx Group, Inc.
- Skye Biologics Inc.
- TissueTech, Inc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 201 |
| Published | March 2022 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 1102.45 million |
| Forecasted Market Value ( USD | $ 1728.05 million |
| Compound Annual Growth Rate | 4.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
